ChemicalBook > CAS DataBase List > 3H-IMidazo[4,5-b]pyridine, 6-chloro-7-[4-[(4-chlorophenyl)Methyl]-1-piperazinyl]-2-(1,3-diMethyl-1H-pyrazol-4-yl)-
3H-IMidazo[4,5-b]pyridine, 6-chloro-7-[4-[(4-chlorophenyl)Methyl]-1-piperazinyl]-2-(1,3-diMethyl-1H-pyrazol-4-yl)-
3H-IMidazo[4,5-b]pyridine, 6-chloro-7-[4-[(4-chlorophenyl)Methyl]-1-piperazinyl]-2-(1,3-diMethyl-1H-pyrazol-4-yl)-
- CAS No.1402709-93-6
- Chemical Name:3H-IMidazo[4,5-b]pyridine, 6-chloro-7-[4-[(4-chlorophenyl)Methyl]-1-piperazinyl]-2-(1,3-diMethyl-1H-pyrazol-4-yl)-
- CBNumber:CB12668045
- Molecular Formula:C22H23Cl2N7
- Formula Weight:456.37
- MOL File:1402709-93-6.mol
3H-IMidazo[4,5-b]pyridine, 6-chloro-7-[4-[(4-chlorophenyl)Methyl]-1-piperazinyl]-2-(1,3-diMethyl-1H-pyrazol-4-yl)- Property
- storage temp. Store at -20°C
- solubility DMSO:75.0(Max Conc. mg/mL);164.34(Max Conc. mM)
- form A crystalline solid
- color White to off-white
- FDA UNII ZE94SP78UG
-
Symbol(GHS)
- Signal wordWarning
- Hazard statements H302-H315-H319-H335
- Precautionary statements P261-P305+P351+P338
3H-IMidazo[4,5-b]pyridine, 6-chloro-7-[4-[(4-chlorophenyl)Methyl]-1-piperazinyl]-2-(1,3-diMethyl-1H-pyrazol-4-yl)- Chemical Properties,Usage,Production
- Uses CCT241736 is a potent and orally bioavailable dual FLT3 and Aurora kinase inhibitor, which inhibits Aurora kinases (Aurora-A Kd, 7.5 nM, IC50, 38 nM; Aurora-B Kd, 48 nM), FLT3 kinase (Kd, 6.2 nM), and FLT3 mutants including FLT3-ITD (Kd, 38 nM) and FLT3(D835Y) (Kd, 14 nM).
-
in vivo
CCT241736 (50, 100 mg/kg, b.i.d, p.o.) dose-dependently suppresses the growth of MV4-11 human tumor xenografts, and completely abolishes the tumors at 100 mg/kg via p.o. administration twice a day[1].
- IC 50 Aurora-A: 38 nM (IC50); Aurora-A: 7.5 nM (Kd); Aurora-B: 48 nM (Kd); FLT3(K663Q): 5.1 nM (Kd); FLT3: 6.2 nM (Kd); FLT3(D835H): 11 nM (Kd); FLT3(D835Y): 14 nM (Kd); FLT3(N841I): 16 nM (Kd); FLT3-ITD: 38 nM (Kd); FLT3(R834Q): 110 nM (Kd)
- References [1] Bavetsias V, et al. Optimization of imidazo[4,5-b]pyridine-based kinase inhibitors: identification of a dual FLT3/Aurora kinase inhibitor as an orally bioavailable preclinical development candidate for the treatment of acute myeloid leukemia. J Med Chem. 2012 Oct 25;55(20):8721-34. DOI:10.1021/jm300952s
3H-IMidazo[4,5-b]pyridine, 6-chloro-7-[4-[(4-chlorophenyl)Methyl]-1-piperazinyl]-2-(1,3-diMethyl-1H-pyrazol-4-yl)- Preparation Products And Raw materials
Raw materials
Preparation Products
3H-IMidazo[4,5-b]pyridine, 6-chloro-7-[4-[(4-chlorophenyl)Methyl]-1-piperazinyl]-2-(1,3-diMethyl-1H-pyrazol-4-yl)- Suppliers
Global(45)Suppliers
-
Supplier:
- Tel:+undefined-21-51877795
- Email:ivan@atkchemical.com
- Country:China
- ProdList:33024
- Advantage:60
-
Supplier:
- Tel:
- Email:support@targetmol.com
- Country:United States
- ProdList:38660
- Advantage:58
- Supplier: BOC Sciences
- Tel:1-631-485-4226;<br/>16314854226
- Email:info@bocsci.com
- Country:United States
- ProdList:12952
- Advantage:65
- Supplier: Shanghai Lollane Biological Technology Co.,Ltd.
- Tel:021-52996696,15000506266<br/>15000506266
- Email:
- Country:China
- ProdList:4611
- Advantage:55
- Supplier: BOC Sciences
- Tel: 16314854226
- Email:info@bocsci.com
- Country:United States
- ProdList:9923
- Advantage:65
- Supplier: ShangHai Biochempartner Co.,Ltd
- Tel:17754423994<br/>17754423994
- Email:2853530910@QQ.com
- Country:China
- ProdList:8011
- Advantage:62
- Supplier: Shanghai Chaolan Chemical Technology Center
- Tel:021-QQ:65489617<br/>15618227136
- Email:Sales@ATKchemical.com
- Country:China
- ProdList:9342
- Advantage:58
- Supplier: Shanghai SuperLan Chemcial Technique Centre
- Tel:021-2022843681<br/>15618226720
- Email:lucy@atkchemical.com
- Country:China
- ProdList:10123
- Advantage:58
- Supplier: Twochem Co.Ltd.
- Tel:021-58111628<br/>15800915896
- Email:sales@twochem.com
- Country:China
- ProdList:1788
- Advantage:58
- Supplier: Fan De(Beijing) Biotechnology Co., Ltd.
- Tel: 15911056312
- Email:liming@bio-fount.com
- Country:China
- ProdList:9729
- Advantage:58
3H-IMidazo[4,5-b]pyridine, 6-chloro-7-[4-[(4-chlorophenyl)Methyl]-1-piperazinyl]-2-(1,3-diMethyl-1H-pyrazol-4-yl)- Spectrum
1402709-93-6, 3H-IMidazo[4,5-b]pyridine, 6-chloro-7-[4-[(4-chlorophenyl)Methyl]-1-piperazinyl]-2-(1,3-diMethyl-1H-pyrazol-4-yl)-Related Search:
- API
- 抑制剂
- 标准品
- C22H23Cl2N7
- 化合物CCT241736,10 MM DMSO 溶液
- 6-氯-7-(4-(4-氯苄基)哌嗪-1-基)-2-(1,3-二甲基-1H-吡唑-4-基)-1H-咪唑并[4,5-B]吡啶
- 化合物CCT241736
- 1402709-93-6
- CCT241736, 10 mM in DMSO
- 1-[6-chloro-2-(1,3-dimethyl-1H-pyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-4-[(4-chlorophenyl)methyl]piperazine
- CCT 241736,Fms like tyrosine kinase 3,CCT241736,CD135,Inhibitor,FLT3,CCT-241736,Aurora Kinase,Cluster of differentiation antigen 135,inhibit
- 6-Chloro-7-(4-(4-chlorobenzyl)piperazin-1-yl)-2-(1,3-dimethyl-1H-pyrazol-4-yl)-1H-imidazo[4,5-b]pyridine
- CS-2683
- CCT241736;CCT-241736;CCT 241736
- CCT241736
- 6-chloro-7-[4-[(4-chlorophenyl)methyl]piperazin-1-yl]-2-(1,3-dimethylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine
- 3H-IMidazo[4,5-b]pyridine, 6-chloro-7-[4-[(4-chlorophenyl)Methyl]-1-piperazinyl]-2-(1,3-diMethyl-1H-pyrazol-4-yl)-